These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 34711181

  • 1. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS, Basma NJ, Amaral FMR, Wiseman DH, Somervaille TCP.
    BMC Cancer; 2021 Oct 28; 21(1):1153. PubMed ID: 34711181
    [Abstract] [Full Text] [Related]

  • 2. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
    Daga S, Rosenberger A, Quehenberger F, Krisper N, Prietl B, Reinisch A, Zebisch A, Sill H, Wölfler A.
    Cancer Med; 2019 Apr 28; 8(4):1771-1778. PubMed ID: 30848055
    [Abstract] [Full Text] [Related]

  • 3. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
    de Figueiredo-Pontes LL, Pintão MC, Oliveira LC, Dalmazzo LF, Jácomo RH, Garcia AB, Falcão RP, Rego EM.
    Cytometry B Clin Cytom; 2008 May 28; 74(3):163-8. PubMed ID: 18200595
    [Abstract] [Full Text] [Related]

  • 4. FOXM1 contributes to treatment failure in acute myeloid leukemia.
    Khan I, Halasi M, Patel A, Schultz R, Kalakota N, Chen YH, Aardsma N, Liu L, Crispino JD, Mahmud N, Frankfurt O, Gartel AL.
    JCI Insight; 2018 Aug 09; 3(15):. PubMed ID: 30089730
    [Abstract] [Full Text] [Related]

  • 5. FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML.
    Sheng Y, Yu C, Liu Y, Hu C, Ma R, Lu X, Ji P, Chen J, Mizukawa B, Huang Y, Licht JD, Qian Z.
    Nat Commun; 2020 Feb 17; 11(1):928. PubMed ID: 32066721
    [Abstract] [Full Text] [Related]

  • 6. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A, Gillis D, Lewis I.
    J Hematol Oncol; 2016 Jul 27; 9(1):61. PubMed ID: 27465508
    [Abstract] [Full Text] [Related]

  • 7. 5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts.
    Dembitz V, Lalic H, Kodvanj I, Tomic B, Batinic J, Dubravcic K, Batinic D, Bedalov A, Visnjic D.
    BMC Cancer; 2020 Nov 11; 20(1):1090. PubMed ID: 33176741
    [Abstract] [Full Text] [Related]

  • 8. FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome.
    Wang L, Gao L, Xu S, Gong S, Chen L, Lü S, Chen J, Qiu H, Xu X, Ni X, Song X, Zhang W, Yang J, Liu M, Hu X, Wang J.
    J Hematol Oncol; 2013 Nov 07; 6(1):85. PubMed ID: 24517186
    [Abstract] [Full Text] [Related]

  • 9. Single-cell dissection reveals promotive role of ENO1 in leukemia stem cell self-renewal and chemoresistance in acute myeloid leukemia.
    Tian Y, Guo J, Mao L, Chen Z, Zhang X, Li Y, Zhang Y, Zha X, Luo OJ.
    Stem Cell Res Ther; 2024 Oct 08; 15(1):347. PubMed ID: 39380054
    [Abstract] [Full Text] [Related]

  • 10. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.
    Sasca D, Szybinski J, Schüler A, Shah V, Heidelberger J, Haehnel PS, Dolnik A, Kriege O, Fehr EM, Gebhardt WH, Reid G, Scholl C, Theobald M, Bullinger L, Beli P, Kindler T.
    Blood; 2019 May 23; 133(21):2305-2319. PubMed ID: 30814062
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.
    Witte KE, Ahlers J, Schäfer I, André M, Kerst G, Scheel-Walter HG, Schwarze CP, Pfeiffer M, Lang P, Handgretinger R, Ebinger M.
    Pediatr Hematol Oncol; 2011 Mar 23; 28(2):91-9. PubMed ID: 21214408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CD117/CD34 expression in leukemic blasts.
    Wells SJ, Bray RA, Stempora LL, Farhi DC.
    Am J Clin Pathol; 1996 Aug 23; 106(2):192-5. PubMed ID: 8712172
    [Abstract] [Full Text] [Related]

  • 18. Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.
    Zhou Y, Moon A, Hoyle E, Fromm JR, Chen X, Soma L, Salipante SJ, Wood BL, Wu D.
    Cytometry B Clin Cytom; 2019 Jan 23; 96(1):67-72. PubMed ID: 30417521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis.
    Yi L, Zhou L, Luo J, Yang Q.
    Blood Cells Mol Dis; 2021 Feb 23; 86():102506. PubMed ID: 33126007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.